Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter

Your Location：

Home >

Browse articles >

Updated：2026-03-12

- Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter
- Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter
- 解放军医学杂志（英文版） 1998年0卷第3期页码：178-182
- Affiliations：
- Author bio：
- Funds：
- DOI：
  中图分类号： R456
- 纸质出版：1998
- Accepted：
Scan QR Code
Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter[J]. 解放军医学杂志（英文版）, 1998,0(3):178-182.

Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter[J]. Military Medical Research1998, 0(3): 178-182.
Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter[J]. 解放军医学杂志（英文版）, 1998,0(3):178-182. DOI：

Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter[J]. Military Medical Research1998, 0(3): 178-182. DOI：

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research

Ionizable drug delivery systems for efficient and selective gene therapy

Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3